Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, United States of America.
Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, United States of America.
PLoS One. 2022 Nov 10;17(11):e0276457. doi: 10.1371/journal.pone.0276457. eCollection 2022.
Conversion of sputum culture from positive to negative for M. tuberculosis is a key indicator of treatment response. An initial positive culture is a pre-requisite to observe conversion. Consequently, patients with a missing or negative initial culture are excluded from analyses of conversion outcomes. To identify the initial, or "baseline" culture, researchers must define a sample collection interval. An interval extending past treatment initiation can increase sample size but may introduce selection bias because patients without a positive pre-treatment culture must survive and remain in care to have a culture in the post-treatment interval.
We used simulated data and data from the endTB observational cohort to investigate the potential for bias when extending baseline culture intervals past treatment initiation. We evaluated bias in the proportion with six-month conversion.
In simulation studies, the potential for bias depended on the proportion of patients missing a pre-treatment culture, proportion with conversion, proportion culture positive at treatment initiation, and proportion of patients missing a pre-treatment culture who would have been observed to be culture positive, had they had a culture. In observational data, the maximum potential for bias when reporting the proportion with conversion reached five percentage points in some sites.
Extending the allowable baseline interval past treatment initiation may introduce selection bias. If investigators choose to extend the baseline collection interval past treatment initiation, the proportion missing a pre-treatment culture and the number of deaths and losses to follow up during the post-treatment allowable interval should be clearly enumerated.
结核分枝杆菌痰培养由阳性转为阴性是治疗反应的关键指标。初始阳性培养是观察转化的先决条件。因此,初始培养缺失或为阴性的患者被排除在转化结果分析之外。为了确定初始(或“基线”)培养物,研究人员必须定义样本采集间隔。延长至治疗开始后的间隔可以增加样本量,但可能会引入选择偏倚,因为没有治疗前阳性培养物的患者必须存活并继续接受治疗,才能在治疗后间隔进行培养。
我们使用模拟数据和 endTB 观察队列的数据,研究了在治疗开始后延长基线培养间隔时可能存在的偏倚。我们评估了六个月内转化比例的偏倚。
在模拟研究中,偏倚的可能性取决于未进行治疗前培养的患者比例、转化的比例、治疗开始时培养阳性的比例,以及如果他们进行了培养,将会观察到治疗前培养缺失但培养阳性的患者比例。在观察性数据中,在某些地点报告转化比例时,最大的偏倚潜力达到了五个百分点。
在治疗开始后延长允许的基线间隔可能会引入选择偏倚。如果研究人员选择延长基线采集间隔至治疗开始后,应明确列出治疗后允许间隔期间缺失治疗前培养物的比例以及死亡和失访的数量。